药物对比
Semaglutide vs Insulin Icodec
比较Semaglutide（Ozempic）与Insulin Icodec（Awiqli）治疗糖尿病。Semaglutide有助于减重并有心血管获益；Icodec提供每周一次胰岛素给药但有低血糖风险。
此页面暂无可用的对比维度。
临床背景
This comparison occurs when choosing between a GLP-1 agonist and once-weekly basal insulin for improved control in type 2 diabetes.
结论
Semaglutide typically provides superior weight management and cardioprotection versus Insulin Icodec, though insulin may be required for some; personalized evaluation is needed.
全部药物对比